View Single Post
Old 09-05-2014, 07:22 PM   #4
anna4969
Senior Member
 
anna4969's Avatar
 
Join Date: Aug 2010
Posts: 72
Smile Re: ASCO Breast Symposium- GP2 her2 vaccine reduces recurrence rates by 57%

Lani,

Thank you, thank you!!! Have been waiting for this information for 3 years!!! I was in the phase 1 trial with Dr. Mittendorf in 2011. This has made my day, my year, my life. I am beyond grateful to Dr. Mittendorf, Dr. Peoples for working so hard at this. I thank the Dear Lord every single day that I was given the opportunity to be a part of this trial.

This all being said, and I know 'Lizbeth and I have stressed this several times before, so once again, anyone looking for a clinical trial to perhaps add a little more insurance to their survival, should very much think about participating in one of these vaccine clinical trials: E75, AE37 and GP2. The side effects are so minimal and this is an add on to standard of care. So a little extra insurance.

Be Well Everyone
__________________
1/10 rt. breast IDC er/pr - Her +++
9cm. tumor, 8-9 + nodes
Neoadj. FACT & beloved H!!, radiation, Dbl. Mast. Diep recons.
GP2 Vaccine completed 5/11
anna4969 is offline   Reply With Quote